SeaCrest Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.02M | Buy |
84,062
+11,995
| +17% | +$314K | 0.22% | 87 |
|
|
2026
Q1 | $2.02M | Buy |
72,067
+3,886
| +6% | +$103K | 0.22% | 83 |
|
|
2025
Q4 | $1.72M | Buy |
68,181
+3,753
| +6% | +$94.6K | 0.17% | 103 |
|
|
2025
Q3 | $1.65M | Sell |
64,428
-22,128
| -26% | -$546K | 0.17% | 104 |
|
|
2025
Q2 | $2.1M | Buy |
86,556
+18,226
| +27% | +$425K | 0.23% | 82 |
|
|
2025
Q1 | $1.73M | Buy |
68,330
+2,740
| +4% | +$71.7K | 0.2% | 92 |
|
|
2024
Q4 | $1.74M | Sell |
65,590
-6,705
| -9% | -$182K | 0.18% | 96 |
|
|
2024
Q3 | $2.09M | Buy |
72,295
+4,262
| +6% | +$124K | 0.23% | 81 |
|
|
2024
Q2 | $1.9M | Buy |
68,033
+3,032
| +5% | +$83.5K | 0.22% | 82 |
|
|
2024
Q1 | $1.8M | Sell |
65,001
-44,655
| -41% | -$1.24M | 0.22% | 89 |
|
|
2023
Q4 | $3.23M | Sell |
109,656
-15,956
| -13% | -$482K | 0.4% | 44 |
|
|
2023
Q3 | $4.17M | Sell |
125,612
-2,940
| -2% | -$104K | 0.54% | 31 |
|
|
2023
Q2 | $4.72M | Buy |
128,552
+5,512
| +4% | +$215K | 0.6% | 24 |
|
|
2023
Q1 | $5.02M | Sell |
123,040
-8,204
| -6% | -$354K | 0.68% | 22 |
|
|
2022
Q4 | $6.72M | Sell |
131,244
-1,547
| -1% | -$74.2K | 0.96% | 12 |
|
|
2022
Q3 | $5.81M | Sell |
132,791
-7,735
| -6% | -$376K | 0.88% | 16 |
|
|
2022
Q2 | $7.37M | Buy |
140,526
+2,528
| +2% | +$129K | 0.93% | 9 |
|
|
2022
Q1 | $7.14M | Sell |
137,998
-57,549
| -29% | -$2.99M | 0.82% | 13 |
|
|
2021
Q4 | $11.5M | Buy |
195,547
+22,174
| +13% | +$1.1M | 1.27% | 9 |
|
|
2021
Q3 | $7.46M | Buy |
173,373
+30,959
| +22% | +$1.37M | 0.9% | 12 |
|
|
2021
Q2 | $5.58M | Buy |
142,414
+18,261
| +15% | +$710K | 0.67% | 22 |
|
|
2021
Q1 | $4.5M | Buy |
124,153
+5,867
| +5% | +$208K | 0.6% | 31 |
|
|
2020
Q4 | $4.35M | Sell |
118,286
-18,791
| -14% | -$689K | 0.61% | 30 |
|
|
2020
Q3 | $4.77M | Buy |
137,077
+18,218
| +15% | +$639K | 0.76% | 23 |
|
|
2020
Q2 | $3.69M | Buy |
118,859
+3,889
| +3% | +$132K | 0.64% | 30 |
|
|
2020
Q1 | $3.56M | Sell |
114,970
-11,104
| -9% | -$378K | 0.77% | 25 |
|
|
2019
Q4 | $4.69M | Buy |
126,074
+15,519
| +14% | +$553K | 0.79% | 19 |
|
|
2019
Q3 | $3.77M | Buy |
110,555
+10,846
| +11% | +$394K | 0.71% | 23 |
|
|
2019
Q2 | $4.1M | Buy |
99,709
+1,481
| +2% | +$58.8K | 0.83% | 19 |
|
|
2019
Q1 | $3.96M | Sell |
98,228
-5,318
| -5% | -$213K | 0.68% | 21 |
|
|
2018
Q4 | $4.29M | Sell |
103,546
-4,280
| -4% | -$178K | 0.88% | 15 |
|
|
2018
Q3 | $4.51M | Buy |
107,826
+1,086
| +1% | +$41.8K | 0.76% | 17 |
|
|
2018
Q2 | $3.67M | Sell |
106,740
-1,635
| -2% | -$55.9K | 0.66% | 22 |
|
|
2018
Q1 | $3.65M | Sell |
108,375
-15,516
| -13% | -$533K | 0.67% | 23 |
|
|
2017
Q4 | $4.26M | Buy |
+123,891
| New | +$4.22M | 0.78% | 19 |
|
Other funds holding PFE
SeaCrest Wealth Management's PFE Position: Q2 2026 in Review
SeaCrest Wealth Management increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $314K and bringing the position to 84,062 shares worth $2.02M. The position accounts for 0.22% of the portfolio, ranked #87.
SeaCrest Wealth Management first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $11.5M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- SeaCrest Wealth Management held 84,062 shares of Pfizer worth $2.02M as of Q2 2026.
- SeaCrest Wealth Management bought 11,995 Pfizer shares in Q2 2026, an estimated $314K.
- Pfizer made up 0.22% of SeaCrest Wealth Management's portfolio in Q2 2026, its #87 holding.
- SeaCrest Wealth Management first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Pfizer position peaked at $11.5M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.